Often dealt with as an aside, mental health can be as significant as physical health, for both rare disease patients and caregivers. A recent survey by Rare Patient Voice highlights the effects of rare disease on mental health and the impact on all aspects of life when a patient and caregiver’s emotional wellbeing is not addressed and supported

For people living with rare diseases, and for the family caregivers who support them, mental health is not separate from physical health. It is part of everyday life. It affects how people cope, how they make decisions and how they manage the long and often uncertain journey of rare disease.

Yet mental health is still too often treated as a “secondary” issue, something to address only after physical symptoms are managed. For the rare disease community, that separation does not reflect reality.

New research from Rare Patient Voice shows just how deeply mental health is woven into the rare disease experience. Based on a late 2025 survey of 958 rare disease patients and caregivers in the United States, the findings are clear: emotional distress is common, ongoing and often overwhelming.

According to the survey, 82.4% of respondents experience frequent emotional distress that interferes with daily life. This distress is not rare, temporary or limited to a small group. It is the norm for many people living with or caring for someone with a rare condition.

When we truly listen to the patient’s voice, one message comes through loud and clear: mental health support is not optional, it’s essential, for both patients and family caregivers.

Emotional stress is part of daily life for many

One of the most striking findings from the survey is how similar patients’ and caregivers’ experiences are. Both groups reported nearly the same levels of emotional distress. This reminds us that rare disease does not affect just one person, it affects entire families.

Survey respondents shared that:

• 82.7% feel anxiety about the future
• 75.1% say medical uncertainty causes significant stress
• More than four out of five say emotional distress regularly gets in the way of daily life

These feelings are not short-lived reactions. For many people in the rare disease community, stress and anxiety build over years of searching for answers, managing symptoms and facing an uncertain future.

Patients often live with constant “what ifs”. What will tomorrow look like? Will symptoms worsen? Will a treatment stop working? Loved ones providing care carry their own emotional load, balancing advocacy, coordination of care and worry for their loved one, often while putting their own needs last.

The survey results reflect what many patients and caregivers already know: emotional strain is not a weakness. It is a natural response to living in a system that is complex, unpredictable and often isolating.

Mental health affects care, research and daily functioning

Mental health matters because it shapes how people function day to day but it also affects the larger rare disease ecosystem. When emotional distress is high, it can become harder to:

• keep up with complex treatment plans
• attend frequent medical appointments
• track symptoms consistently
• take part in research studies or clinical trials

Living with anxiety, depression or emotional exhaustion takes energy. Many patients and caregivers simply do not have extra capacity to spare.

Caregiver burnout is another critical concern. When caregivers are stretched too thin for too long, it can affect their ability to provide support over time. This, in turn, can affect patient stability and outcomes.

From a research standpoint, emotional distress can influence how patients report symptoms, complete surveys or stay engaged in long-term studies. When mental health needs are ignored, it can impact participation, retention and the quality of patient-reported data.

Mental health is not just a personal issue. It affects treatment adherence, research quality and overall outcomes in rare disease.

A large gap between need and support

Despite how common emotional distress is, the survey found that only 30% of respondents have accessed professional mental health services. This gap points to a serious unmet need in the rare disease community.

Patients and caregivers face many barriers when trying to get help, including:

• difficulty finding mental health providers who understand rare disease
• cost or insurance limitations
• lack of time due to caregiving or medical demands
• emotional exhaustion that makes seeking help feel like “one more thing”

For some, traditional mental health care does not feel equipped to address the realities of rare disease life. Having to explain a rare condition again and again, or feeling misunderstood by providers, can be discouraging.

Listening to the patient’s voice means recognising that access to care is not just about availability. Support must feel relevant, informed and compassionate to truly help.

Elevating patient and caregiver voices through research

Rare Patient Voice is dedicated to making sure patients and family caregivers are heard, not just through individual stories, but through participation in research and the resulting large-scale data that reflects real-world experience. This white paper brings mental health to the forefront by letting the community speak for itself.

The full findings are available in the Rare Patient Voice white paper, “The Critical Need to Address Mental Health in the Rare Disease Community,” which can be accessed here:
https://rarepatientvoice.com/wp-content/uploads/2025/12/Mental-Health-and-Rare-Disease-White-Paper.pdf

The white paper shows clearly that emotional distress is widespread, shared by patients and caregivers alike, and closely tied to the realities of living with rare disease.

Continuing the conversation: December 2025 webinar

These findings were discussed in a December 2025 webinar hosted by Rare Patient Voice, featuring senior vice president Pam Cusick and patient advocate Chris Anselmo.

During the webinar, Pam discussed how patient-reported data can help researchers, healthcare providers and life sciences organisations better understand the full rare disease experience, including mental health. Chris Anselmo shared personal insights into the emotional toll of rare disease and the importance of feeling seen and heard.

Together, they emphasised that real progress starts by listening to patients and caregivers themselves.

The archived webinar is available to watch here: https://ln5.sync.com/dl/7d4fb7d20#mjn68kw6-ad3ypwcb-k68rt9xv-7gfrj4nt

What this means for the rare disease community

For patients and caregivers, this research offers validation. Emotional distress is not a personal failure, it’s a shared experience shaped by real challenges. Recognising this can help reduce stigma and open the door to more honest conversations about mental health.

For advocacy groups and healthcare providers, the findings highlight the need to treat mental health as part of whole-person care.

For researchers and life sciences organisations, the data shows why mental health must be considered when designing studies, engaging participants and interpreting results. Supporting emotional well-being can improve trust, participation and long-term engagement.

Across all groups, the message is the same: the patient voice matters.

Moving forward by listening

Mental health is a central part of the rare disease experience. The Rare Patient Voice white paper and accompanying webinar make it clear that addressing emotional well-being is not only compassionate, it is necessary for better care, better research and better outcomes.

By listening to patients and caregivers, we can build systems that are more understanding, more supportive and more effective. Because when the patient voice is truly heard, it has the power to drive real change.

---

Rare Patient Voice are the proud sponsors of the Patient Voice section of RARE Revolution for February, March and April 2026. They provide patients and family caregivers an opportunity to participate in all types of research including market research, health economics outcomes and real-world evidence, user experience/human factors studies and clinical trials. The RPV community includes over 185,000 patients and family caregivers across more than 1,500 diseases, both rare and non-rare, in nine countries. Learn more here.

---